First synthesis, characterization, and evidence for the presence of hydroxycinnamic acid sulfate and glucuronide conjugates in human biological fluids as a result of coffee consumption.
Org Biomol Chem. 2010 Nov 21; 8(22):5199-211.OB

Abstract

A systematic investigation of the human metabolism of hydroxycinnamic acid conjugates was carried out. A set of 24 potential human metabolites of coffee polyphenols has been chemically prepared, and used as analytical standards for unequivocal identifications. These included glucuronide conjugates and sulfate esters of caffeic, ferulic, isoferulic, m-coumaric and p-coumaric acids as well as their dihydro derivatives. A particular focus has been made on caffeic and 3,4-dihydroxyphenylpropionic acid derivatives, especially the sulfate conjugates, for which regioselective preparation was particularly challenging, and have so far never been identified as human metabolites. Ten out of the 24 synthesized conjugates have been identified in human plasma and/or urine after coffee consumption. A number of these conjugates were synthesized, characterized and detected as hydroxycinnamic acid metabolites for the first time. This was the case of dihydroisoferulic acid 3'-O-glucuronide, caffeic acid 3'-sulfate, as well as the sulfate and glucuronide derivatives of 3,4-dihydroxyphenylpropionic acid.

Links

Publisher Full Text

Authors+Show Affiliations

Fumeaux R
Nestlé Research Center, PO Box 44, CH-1000, Lausanne 26, Switzerland.
Menozzi-Smarrito C
No affiliation info available
Stalmach A
No affiliation info available
Munari C
No affiliation info available
Kraehenbuehl K
No affiliation info available
Steiling H
No affiliation info available
Crozier A
No affiliation info available
Williamson G
No affiliation info available
Barron D
No affiliation info available

MeSH

Body FluidsCaffeic AcidsChlorogenic AcidChromatography, High Pressure LiquidCoffeeCoumaric AcidsDrinking BehaviorGlucuronidesHumansMagnetic Resonance SpectroscopyMass SpectrometrySulfuric Acid Esters

Pub Type(s)

Clinical Trial
Journal Article

Language

eng

PubMed ID

20842300